DK2303314T3 - Chloramphenicol-acetyltransferase (cat)-defekt somatostatin-fusionsprotein og anvendelser deraf til kvæg - Google Patents

Chloramphenicol-acetyltransferase (cat)-defekt somatostatin-fusionsprotein og anvendelser deraf til kvæg

Info

Publication number: DK2303314T3
Authority: DK; Denmark
Prior art keywords: cattle; cat; defect; fusion protein; acetyl transferase
Prior art date: 2008-06-25

Application number

DK08771936.5T

Other languages

English (en)

Inventor

Andrew R Mendelsohn

Keith N Haffer

James Larrick

Original Assignee

Braasch Biotech Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-25

Filing date

2008-06-25

Publication date

2014-01-13

2008-06-25 Application filed by Braasch Biotech Llc filed Critical Braasch Biotech Llc

2014-01-13 Application granted granted Critical

2014-01-13 Publication of DK2303314T3 publication Critical patent/DK2303314T3/da

Links

108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 title 2
102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
230000007547 defect Effects 0.000 title 1
108020001507 fusion proteins Proteins 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01028—Chloramphenicol O-acetyltransferase (2.3.1.28)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Polymers & Plastics (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Birds (AREA)
Animal Husbandry (AREA)
General Chemical & Material Sciences (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Food Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

DK08771936.5T 2008-06-25 2008-06-25 Chloramphenicol-acetyltransferase (cat)-defekt somatostatin-fusionsprotein og anvendelser deraf til kvæg DK2303314T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/068195 WO2009157926A1 (en)	2008-06-25	2008-06-25	Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Publications (1)

Publication Number	Publication Date
DK2303314T3 true DK2303314T3 (da)	2014-01-13

Family

ID=41444809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08771936.5T DK2303314T3 (da)	2008-06-25	2008-06-25	Chloramphenicol-acetyltransferase (cat)-defekt somatostatin-fusionsprotein og anvendelser deraf til kvæg

Country Status (16)

Country	Link
US (3)	US7722881B2 (da)
EP (1)	EP2303314B1 (da)
JP (1)	JP5506792B2 (da)
KR (1)	KR101555731B1 (da)
CN (1)	CN102105163B (da)
AU (1)	AU2008358353B2 (da)
BR (1)	BRPI0822826A2 (da)
CA (1)	CA2728734A1 (da)
DK (1)	DK2303314T3 (da)
ES (1)	ES2445403T3 (da)
IL (1)	IL209792A (da)
MX (1)	MX2010014082A (da)
NZ (1)	NZ590011A (da)
RU (1)	RU2501565C2 (da)
WO (1)	WO2009157926A1 (da)
ZA (1)	ZA201009125B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2519051C2 (ru)	2008-06-25	2014-06-10	Брааш Биотех Ллк	Композиции и способы для улучшенной иммуногенности соматостатина в лечении дефицита гормона роста и инсулиноподобного фактора роста
RU2501565C2 (ru)	2008-06-25	2013-12-20	Брааш Биотех Ллк	Слитый белок дефектная хлорамфеникол ацетилтрансфераза (сат)-соматостатин и его применения
US20150173333A1 (en) *	2012-06-26	2015-06-25	Biovalence Sdn. Bhd.	Rapid specific pathogen free animal
KR102066768B1 (ko)	2012-11-08	2020-01-15	피 파르마 에스에이	C4s 프로테오글리칸 특이적 트랜스포터 분자
RU2526571C1 (ru) *	2013-04-08	2014-08-27	Сергей Михайлович Юдин	Инъекционный препарат для повышения спермопродукции человека и способ его применения
WO2016029013A2 (en)	2014-08-21	2016-02-25	Braasch Biotech Llc	Methods for improving immunological response in vaccinated animals
WO2021024020A1 (en)	2019-08-06	2021-02-11	Astellas Pharma Inc.	Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4342832A (en)	1979-07-05	1982-08-03	Genentech, Inc.	Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4446235A (en)	1982-03-22	1984-05-01	Genentech, Inc.	Method for cloning human growth hormone varient genes
JP2602968B2 (ja)	1987-11-04	1997-04-23	カリフォルニアバイオテクノロジーインコーポレイテッド	肺胞の界面活性タンパク類
RU2034457C1 (ru) *	1993-06-22	1995-05-10	Товарищество с ограниченной ответственностью "Ветек"	Способ повышения продуктивности сельскохозяйственных животных и препарат для его осуществления
EP0645454A3 (en) *	1993-06-22	1997-01-15	Vladimir Glebovich Lunin	Protein containing a chimeric somatostatin, coding DNA, immunogenic compositions, and method for improving the productivity of farmes animals.
US6025368A (en)	1997-02-25	2000-02-15	Celtrix Pharmaceuticals, Inc.	Method for treating the symptoms of chronic stress-related disorders using IGF
US20070048860A1 (en)	1997-10-10	2007-03-01	The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services	Carcinoembryonic antigen (CEA) peptides
PL213561B1 (pl)	2004-01-09	2013-03-29	Inst Biotechnologii I Antybiotykow	Sposób otrzymywania plazmidu, plazmid oraz zastosowania
US7998930B2 (en)	2004-11-04	2011-08-16	Hanall Biopharma Co., Ltd.	Modified growth hormones
ZA200711123B (en)	2005-06-27	2009-08-26	Biovail Lab Int Srl	Modified-release formulations of a bupropion salt
RU2519051C2 (ru)	2008-06-25	2014-06-10	Брааш Биотех Ллк	Композиции и способы для улучшенной иммуногенности соматостатина в лечении дефицита гормона роста и инсулиноподобного фактора роста
RU2501565C2 (ru)	2008-06-25	2013-12-20	Брааш Биотех Ллк	Слитый белок дефектная хлорамфеникол ацетилтрансфераза (сат)-соматостатин и его применения

2008
- 2008-06-25 RU RU2011100104/15A patent/RU2501565C2/ru active
- 2008-06-25 NZ NZ590011A patent/NZ590011A/xx not_active IP Right Cessation
- 2008-06-25 ES ES08771936.5T patent/ES2445403T3/es active Active
- 2008-06-25 CA CA2728734A patent/CA2728734A1/en not_active Abandoned
- 2008-06-25 EP EP08771936.5A patent/EP2303314B1/en not_active Not-in-force
- 2008-06-25 CN CN200880130533.4A patent/CN102105163B/zh not_active Expired - Fee Related
- 2008-06-25 DK DK08771936.5T patent/DK2303314T3/da active
- 2008-06-25 AU AU2008358353A patent/AU2008358353B2/en not_active Ceased
- 2008-06-25 JP JP2011516244A patent/JP5506792B2/ja not_active Expired - Fee Related
- 2008-06-25 BR BRPI0822826-4A patent/BRPI0822826A2/pt not_active Application Discontinuation
- 2008-06-25 WO PCT/US2008/068195 patent/WO2009157926A1/en active Application Filing
- 2008-06-25 KR KR1020107029180A patent/KR101555731B1/ko active IP Right Grant
- 2008-06-25 MX MX2010014082A patent/MX2010014082A/es active IP Right Grant
- 2008-08-26 US US12/198,579 patent/US7722881B2/en active Active
2010
- 2010-02-10 US US12/703,631 patent/US7943143B2/en not_active Expired - Fee Related
- 2010-12-06 IL IL209792A patent/IL209792A/en active IP Right Grant
- 2010-12-20 ZA ZA2010/09125A patent/ZA201009125B/en unknown
2011
- 2011-03-23 US US13/069,592 patent/US8367073B2/en active Active

Also Published As

Publication number	Publication date
AU2008358353B2 (en)	2013-11-07
EP2303314B1 (en)	2013-12-11
KR101555731B1 (ko)	2015-09-25
US20100136037A1 (en)	2010-06-03
CA2728734A1 (en)	2009-12-30
CN102105163B (zh)	2014-12-10
ZA201009125B (en)	2012-06-27
RU2011100104A (ru)	2012-07-20
EP2303314A1 (en)	2011-04-06
AU2008358353A1 (en)	2009-12-30
EP2303314A4 (en)	2012-07-18
JP5506792B2 (ja)	2014-05-28
RU2501565C2 (ru)	2013-12-20
US20120076806A1 (en)	2012-03-29
NZ590011A (en)	2012-09-28
US7943143B2 (en)	2011-05-17
IL209792A0 (en)	2011-02-28
US8367073B2 (en)	2013-02-05
US7722881B2 (en)	2010-05-25
KR20110039517A (ko)	2011-04-19
MX2010014082A (es)	2011-04-07
JP2011525914A (ja)	2011-09-29
US20090324629A1 (en)	2009-12-31
ES2445403T3 (es)	2014-03-03
WO2009157926A1 (en)	2009-12-30
BRPI0822826A2 (pt)	2015-07-07
IL209792A (en)	2012-12-31
CN102105163A (zh)	2011-06-22

Publication	Publication Date	Title
DK1973429T3 (da)	2013-10-28	Proteinhydrolysater og fremgangsmåde til fremstilling
DK1877090T3 (da)	2014-04-14	Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
DK2303314T3 (da)	2014-01-13	Chloramphenicol-acetyltransferase (cat)-defekt somatostatin-fusionsprotein og anvendelser deraf til kvæg
DK2079355T3 (da)	2020-03-02	Fremgangsmåde og system til brilleordination
DK3067064T3 (da)	2020-06-08	Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
DK2617823T3 (da)	2015-10-05	Phytaser, nukleinsyrer, der koder for disse, og fremgangsmåde til fremstilling og anvendelse heraf
DK3364298T3 (da)	2020-03-02	System og fremgangsmåde til hukommelseskredsløb
DK2046826T3 (da)	2011-10-24	Exendin-fusionsproteiner
DK1993706T3 (da)	2020-11-02	PSA-trykmåling og styresystem
DK3136030T3 (da)	2019-10-14	Fremgangsmåde til lyofilisering
DK2215213T3 (da)	2013-07-22	Slambaseret tilsætningsstof til dyrfoder og fremgangsmåde til fremstilling heraf
DK2198288T3 (da)	2019-05-13	Fremgangsmåde og indretning til gennemlysning af æg via detektering af embryohjerteslag
DK2029799T3 (da)	2012-12-10	Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
DK2153115T3 (da)	2021-08-30	Led-baserede belysningsarmaturer og relaterede fremgangsmåder til varmestyring
DK1984344T3 (da)	2013-01-14	Multicykliske aminosyrederivater og fremgangsmåder til anvendelse heraf
DK3178490T3 (da)	2022-06-20	RSV F-proteinsammensætninger og fremgangsmåder til fremstilling af disse
DK2214471T3 (da)	2021-01-11	Fremgangsmåde og system til opvarmning og affugtning
DK2337568T3 (da)	2020-05-11	Fremgangsmåder og midler til blødvævsteknologi
DK1888960T3 (da)	2009-11-09	Forankringselement til rörkoblinger
BRPI0819092A2 (pt)	2014-10-14	Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
BRPI0719562A2 (pt)	2014-06-24	Sistema de controle de articulação
DK2019090T3 (da)	2013-01-21	Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf
BRPI0919167A2 (pt)	2015-12-08	sistema de mandíbula de engates e método
DK2190991T3 (da)	2020-02-10	SDF-1-Bindende nucleinsyrer og anvendelsen deraf
NO20074975L (no)	2009-04-06	Fremgangsmate og system for sensorgeometri